Technologies for Direct Detection of Covalent Protein–Drug Adducts
In the past two decades, drug candidates with a covalent binding mode have gained the interest of medicinal chemists, as several covalent anticancer drugs have successfully reached the clinic. As a covalent binding mode changes the relevant parameters to rank inhibitor potency and investigate struct...
Main Authors: | Elma Mons, Robbert Q. Kim, Monique P. C. Mulder |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-04-01
|
Series: | Pharmaceuticals |
Subjects: | |
Online Access: | https://www.mdpi.com/1424-8247/16/4/547 |
Similar Items
-
Covalent Warheads Targeting Cysteine Residue: The Promising Approach in Drug Development
by: Fangjiao Huang, et al.
Published: (2022-11-01) -
Systematic Exploration of Privileged Warheads for Covalent Kinase Drug Discovery
by: Zheng Zhao, et al.
Published: (2022-10-01) -
Extended Applications of Small-Molecule Covalent Inhibitors toward Novel Therapeutic Targets
by: Jesang Lee, et al.
Published: (2022-11-01) -
BIreactive: Expanding the Scope of Reactivity Predictions to Propynamides
by: Markus R. Hermann, et al.
Published: (2023-01-01) -
Reactivity of Covalent Fragments and Their Role in Fragment Based Drug Discovery
by: Kirsten McAulay, et al.
Published: (2022-11-01)